Clinical & Industry News

New resources give hospital administrators, cath lab teams, and policymakers practical tools to implement Enhanced Radiation Safety Devices (ERPDs) and the ALARA+ safety framework.

The sale of a physician-owned cardiovascular surgery center underscores continued investment in outpatient cardiovascular care.

With a record number of ASCs included, the latest Leapfrog ratings expand public reporting of ambulatory surgery center quality and safety, increasing transparency for patients and referring providers.

The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.

First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.

Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.

ESC Press Release Sophia Antipolis, France – 23 July 2026: The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the annual congress of the European Society of Cardiology, which takes...

ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...